A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris suis Ova Treatmen in Left-sided Ulcerative Colitis and its Effects on Mucosal Immunce State and Microbiota. IND Sponsor DAIT/NIAID/NIH and Industry Collborator Coronado Biosciences.
|Effective start/end date||5/1/14 → 4/30/16|
- Duke University (203-4117//5U19AI056363-10REV)
- National Institute of Allergy and Infectious Diseases (203-4117//5U19AI056363-10REV)